CA2525452A1 - Novel 14 and 15 membered-ring compounds - Google Patents
Novel 14 and 15 membered-ring compounds Download PDFInfo
- Publication number
- CA2525452A1 CA2525452A1 CA002525452A CA2525452A CA2525452A1 CA 2525452 A1 CA2525452 A1 CA 2525452A1 CA 002525452 A CA002525452 A CA 002525452A CA 2525452 A CA2525452 A CA 2525452A CA 2525452 A1 CA2525452 A1 CA 2525452A1
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- optionally substituted
- 6alkyl
- ethyl
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0310986.5 | 2003-05-13 | ||
| GBGB0310986.5A GB0310986D0 (en) | 2003-05-13 | 2003-05-13 | Novel compounds |
| PCT/EP2004/005082 WO2004101586A1 (en) | 2003-05-13 | 2004-05-11 | Novel 14 and 15 membered-ring compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2525452A1 true CA2525452A1 (en) | 2004-11-25 |
Family
ID=9957984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002525452A Abandoned CA2525452A1 (en) | 2003-05-13 | 2004-05-11 | Novel 14 and 15 membered-ring compounds |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7569550B2 (enExample) |
| EP (1) | EP1628988B1 (enExample) |
| JP (1) | JP2007502313A (enExample) |
| KR (1) | KR20060026407A (enExample) |
| CN (1) | CN1849328A (enExample) |
| AR (1) | AR044309A1 (enExample) |
| AT (1) | ATE341560T1 (enExample) |
| AU (1) | AU2004238528A1 (enExample) |
| BR (1) | BRPI0410246A (enExample) |
| CA (1) | CA2525452A1 (enExample) |
| CL (1) | CL2004001010A1 (enExample) |
| DE (1) | DE602004002696T2 (enExample) |
| DK (1) | DK1628988T3 (enExample) |
| ES (1) | ES2273255T3 (enExample) |
| GB (1) | GB0310986D0 (enExample) |
| HR (1) | HRP20060448T3 (enExample) |
| MX (1) | MXPA05012163A (enExample) |
| PL (1) | PL1628988T3 (enExample) |
| PT (1) | PT1628988E (enExample) |
| RU (1) | RU2005134908A (enExample) |
| WO (1) | WO2004101586A1 (enExample) |
| ZA (1) | ZA200509079B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0424958D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| WO2007054295A1 (en) * | 2005-11-09 | 2007-05-18 | Glaxo Group Limited | New 4*-substituted erythromycin derivative |
| GB0424961D0 (en) * | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
| DE602006015919D1 (de) * | 2005-01-13 | 2010-09-16 | Glaxosmithkline Zagreb | Makrolide mit entzündungshemmender wirkung |
| JP2008540503A (ja) | 2005-05-10 | 2008-11-20 | グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ | 細菌感染症の処置に有用なエーテル結合マクロライド |
| WO2007054296A1 (en) * | 2005-11-09 | 2007-05-18 | Glaxo Group Limited | Macrolones |
| JP5437394B2 (ja) | 2009-01-30 | 2014-03-12 | グラクソ グループ リミテッド | 抗炎症性マクロライド |
| CN111574575B (zh) * | 2020-04-29 | 2022-05-17 | 北京理工大学 | 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL93936A (en) * | 1989-03-28 | 1994-06-24 | Abbott Lab | History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them |
| WO1996034007A1 (es) * | 1995-04-27 | 1996-10-31 | Laboratorios Aranda, S.A. De C.V. | Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen |
| DE69723848T2 (de) * | 1996-05-07 | 2004-07-01 | Abbott Laboratories, Abbott Park | 3-descladinose-2,3-anhydroerythromycin-derivate |
| GB0025688D0 (en) * | 2000-10-19 | 2000-12-06 | Glaxo Group Ltd | Macrolides |
| JP4311203B2 (ja) * | 2001-08-08 | 2009-08-12 | 大正製薬株式会社 | １１ａ−アザライド化合物及びその製造方法 |
| GB0127349D0 (en) | 2001-11-14 | 2002-01-02 | Glaxo Group Ltd | Macrolides |
-
2003
- 2003-05-13 GB GBGB0310986.5A patent/GB0310986D0/en not_active Ceased
-
2004
- 2004-05-11 DK DK04732102T patent/DK1628988T3/da active
- 2004-05-11 PT PT04732102T patent/PT1628988E/pt unknown
- 2004-05-11 RU RU2005134908/04A patent/RU2005134908A/ru not_active Application Discontinuation
- 2004-05-11 HR HR20060448T patent/HRP20060448T3/xx unknown
- 2004-05-11 PL PL04732102T patent/PL1628988T3/pl unknown
- 2004-05-11 AU AU2004238528A patent/AU2004238528A1/en not_active Abandoned
- 2004-05-11 AT AT04732102T patent/ATE341560T1/de not_active IP Right Cessation
- 2004-05-11 AR ARP040101614A patent/AR044309A1/es not_active Application Discontinuation
- 2004-05-11 CL CL200401010A patent/CL2004001010A1/es unknown
- 2004-05-11 EP EP04732102A patent/EP1628988B1/en not_active Expired - Lifetime
- 2004-05-11 WO PCT/EP2004/005082 patent/WO2004101586A1/en not_active Ceased
- 2004-05-11 BR BRPI0410246-0A patent/BRPI0410246A/pt not_active IP Right Cessation
- 2004-05-11 CA CA002525452A patent/CA2525452A1/en not_active Abandoned
- 2004-05-11 US US10/556,645 patent/US7569550B2/en not_active Expired - Fee Related
- 2004-05-11 DE DE602004002696T patent/DE602004002696T2/de not_active Expired - Lifetime
- 2004-05-11 CN CNA2004800192646A patent/CN1849328A/zh active Pending
- 2004-05-11 ES ES04732102T patent/ES2273255T3/es not_active Expired - Lifetime
- 2004-05-11 JP JP2006529794A patent/JP2007502313A/ja active Pending
- 2004-05-11 MX MXPA05012163A patent/MXPA05012163A/es active IP Right Grant
- 2004-05-11 KR KR1020057021593A patent/KR20060026407A/ko not_active Withdrawn
-
2005
- 2005-11-09 ZA ZA200509079A patent/ZA200509079B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1628988T3 (pl) | 2007-03-30 |
| GB0310986D0 (en) | 2003-06-18 |
| WO2004101586A1 (en) | 2004-11-25 |
| US7569550B2 (en) | 2009-08-04 |
| RU2005134908A (ru) | 2006-06-27 |
| DK1628988T3 (da) | 2007-02-05 |
| AR044309A1 (es) | 2005-09-07 |
| ZA200509079B (en) | 2007-02-28 |
| JP2007502313A (ja) | 2007-02-08 |
| MXPA05012163A (es) | 2006-05-19 |
| AU2004238528A1 (en) | 2004-11-25 |
| CL2004001010A1 (es) | 2005-03-18 |
| DE602004002696D1 (de) | 2006-11-16 |
| KR20060026407A (ko) | 2006-03-23 |
| EP1628988A1 (en) | 2006-03-01 |
| ATE341560T1 (de) | 2006-10-15 |
| CN1849328A (zh) | 2006-10-18 |
| US20070185117A1 (en) | 2007-08-09 |
| BRPI0410246A (pt) | 2006-05-16 |
| EP1628988B1 (en) | 2006-10-04 |
| PT1628988E (pt) | 2007-01-31 |
| HRP20060448T3 (hr) | 2007-03-31 |
| ES2273255T3 (es) | 2007-05-01 |
| DE602004002696T2 (de) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1628989B1 (en) | Novel 14 and 15 membered-ring compounds | |
| US20080090773A1 (en) | Macrolones - Amino Substituted Quinolones | |
| EP1756135B1 (en) | Ester linked macrolides useful for the treatment of microbial infections | |
| EP1628988B1 (en) | Novel 14 and 15 membered-ring compounds | |
| EP1824869A1 (en) | Macrolone compounds | |
| CA2525449A1 (en) | Macrolides substituded at the 4"-position | |
| EP1628990B1 (en) | Novel 14 and 15 membered ring compounds | |
| US20060258600A1 (en) | Ether linked macrolides useful for the treatment of microbial infections | |
| WO2004101589A1 (en) | Novel 14 and 15 membered-ring compounds | |
| EP1633765B1 (en) | Novel 14 and 15 membered-ring compounds | |
| EP1824871A1 (en) | Macrolone compounds | |
| WO2004101584A1 (en) | Macrolides substituted at the 3-position having antimicrobial activity | |
| WO2006120545A1 (en) | 4' amino linked macrolides useful for the treatment of microbial infections | |
| WO2005108413A1 (en) | Carbamate linked macrolides useful for the treatment of microbial infections | |
| EP1824497A1 (en) | Macrolone compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |